Drug Risk Archives - Page 2 of 2 - Pharma Marketing Network

Home Tags Drug Risk

Wolfe Defanged at FDA Advisory Committee Meeting on J&J’s rivaroxaban

Pharma Guy - March 24, 2009

AZ: Let’s Put a Positive Spin on this “Cursed” Study

Pharma Guy - February 27, 2009

Scare Balance or Scare Tactics? A Weak Case Against More DTC...

Pharma Guy - November 21, 2008

How Risky are Rx Drugs?

Pharma Guy - July 17, 2008

12Page 2 of 2

EDITOR PICKS

26th DTC National Conference

March 12, 2026

Informa Connect 2026 Events

January 19, 2026

FDA Pilots Are Changing Healthcare. Here’s What Pharma Marketers Should Do...

January 16, 2026

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

May 27, 2017

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

December 21, 2020

Pharma Marketing News – Past Issues (2016)

January 1, 2017

RECENT POSTS

Pharma compliance professional using AI-powered telehealth marketing compliance dashboard with real-time risk monitoring

The Audit Is Already Obsolete: Pharma’s Shift Toward Compliance-as-Code

May 20, 2026

Doctor facing prior authorization barriers and prescribing friction inside an electronic health record system

The Frictionless Script: Why “Covered” Drugs Still Fail at the Point...

May 19, 2026

Pharmaceutical communications team monitoring market sentiment and FDA advisory vote outcomes during a critical 48-hour response window.

The 48-Hour Window: What Happens After an FDA Advisory Vote Can...

May 19, 2026